United States Non-Alcoholic Steatohepatitis Drug Market Report 2016

December 2016 | 103 pages | ID: UFBB5CBB6ADEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Non-Alcoholic Steatohepatitis Drug

Revenue, means the sales value of Non-Alcoholic Steatohepatitis Drug

This report studies sales (consumption) of Non-Alcoholic Steatohepatitis Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Genfit SA
• Intercept Pharmaceuticals, Inc.
• Tobira Therapeutics, Inc.
• Galmed Pharmaceuticals Ltd.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Non-Alcoholic Steatohepatitis Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Non-Alcoholic Steatohepatitis Drug Market Report 2016

1 NON-ALCOHOLIC STEATOHEPATITIS DRUG OVERVIEW

1.1 Product Overview and Scope of Non-Alcoholic Steatohepatitis Drug
1.2 Classification of Non-Alcoholic Steatohepatitis Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Non-Alcoholic Steatohepatitis Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Non-Alcoholic Steatohepatitis Drug (2011-2021)
  1.4.1 United States Non-Alcoholic Steatohepatitis Drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Non-Alcoholic Steatohepatitis Drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES NON-ALCOHOLIC STEATOHEPATITIS DRUG COMPETITION BY MANUFACTURERS

2.1 United States Non-Alcoholic Steatohepatitis Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Non-Alcoholic Steatohepatitis Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Non-Alcoholic Steatohepatitis Drug Average Price by Manufactures (2015 and 2016)
2.4 Non-Alcoholic Steatohepatitis Drug Market Competitive Situation and Trends
  2.4.1 Non-Alcoholic Steatohepatitis Drug Market Concentration Rate
  2.4.2 Non-Alcoholic Steatohepatitis Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NON-ALCOHOLIC STEATOHEPATITIS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Non-Alcoholic Steatohepatitis Drug Sales and Market Share by Type (2011-2016)
3.2 United States Non-Alcoholic Steatohepatitis Drug Revenue and Market Share by Type (2011-2016)
3.3 United States Non-Alcoholic Steatohepatitis Drug Price by Type (2011-2016)
3.4 United States Non-Alcoholic Steatohepatitis Drug Sales Growth Rate by Type (2011-2016)

4 UNITED STATES NON-ALCOHOLIC STEATOHEPATITIS DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Non-Alcoholic Steatohepatitis Drug Sales and Market Share by Application (2011-2016)
4.2 United States Non-Alcoholic Steatohepatitis Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES NON-ALCOHOLIC STEATOHEPATITIS DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 Genfit SA
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Non-Alcoholic Steatohepatitis Drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Genfit SA Non-Alcoholic Steatohepatitis Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Intercept Pharmaceuticals, Inc.
  5.2.2 Non-Alcoholic Steatohepatitis Drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Tobira Therapeutics, Inc.
  5.3.2 Non-Alcoholic Steatohepatitis Drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Tobira Therapeutics, Inc. Non-Alcoholic Steatohepatitis Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Galmed Pharmaceuticals Ltd.
  5.4.2 Non-Alcoholic Steatohepatitis Drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Galmed Pharmaceuticals Ltd. Non-Alcoholic Steatohepatitis Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview

6 NON-ALCOHOLIC STEATOHEPATITIS DRUG MANUFACTURING COST ANALYSIS

6.1 Non-Alcoholic Steatohepatitis Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Non-Alcoholic Steatohepatitis Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Non-Alcoholic Steatohepatitis Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Non-Alcoholic Steatohepatitis Drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES NON-ALCOHOLIC STEATOHEPATITIS DRUG MARKET FORECAST (2016-2021)

10.1 United States Non-Alcoholic Steatohepatitis Drug Sales, Revenue Forecast (2016-2021)
10.2 United States Non-Alcoholic Steatohepatitis Drug Sales Forecast by Type (2016-2021)
10.3 United States Non-Alcoholic Steatohepatitis Drug Sales Forecast by Application (2016-2021)
10.4 Non-Alcoholic Steatohepatitis Drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-Alcoholic Steatohepatitis Drug
Table Classification of Non-Alcoholic Steatohepatitis Drug
Figure United States Sales Market Share of Non-Alcoholic Steatohepatitis Drug by Type in 2015
Table Application of Non-Alcoholic Steatohepatitis Drug
Figure United States Sales Market Share of Non-Alcoholic Steatohepatitis Drug by Application in 2015
Figure United States Non-Alcoholic Steatohepatitis Drug Sales and Growth Rate (2011-2021)
Figure United States Non-Alcoholic Steatohepatitis Drug Revenue and Growth Rate (2011-2021)
Table United States Non-Alcoholic Steatohepatitis Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Non-Alcoholic Steatohepatitis Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Non-Alcoholic Steatohepatitis Drug Sales Share by Manufacturers
Figure 2016 Non-Alcoholic Steatohepatitis Drug Sales Share by Manufacturers
Table United States Non-Alcoholic Steatohepatitis Drug Revenue by Manufacturers (2015 and 2016)
Table United States Non-Alcoholic Steatohepatitis Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Non-Alcoholic Steatohepatitis Drug Revenue Share by Manufacturers
Table 2016 United States Non-Alcoholic Steatohepatitis Drug Revenue Share by Manufacturers
Table United States Market Non-Alcoholic Steatohepatitis Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Non-Alcoholic Steatohepatitis Drug Average Price of Key Manufacturers in 2015
Figure Non-Alcoholic Steatohepatitis Drug Market Share of Top 3 Manufacturers
Figure Non-Alcoholic Steatohepatitis Drug Market Share of Top 5 Manufacturers
Table United States Non-Alcoholic Steatohepatitis Drug Sales by Type (2011-2016)
Table United States Non-Alcoholic Steatohepatitis Drug Sales Share by Type (2011-2016)
Figure United States Non-Alcoholic Steatohepatitis Drug Sales Market Share by Type in 2015
Table United States Non-Alcoholic Steatohepatitis Drug Revenue and Market Share by Type (2011-2016)
Table United States Non-Alcoholic Steatohepatitis Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Non-Alcoholic Steatohepatitis Drug by Type (2011-2016)
Table United States Non-Alcoholic Steatohepatitis Drug Price by Type (2011-2016)
Figure United States Non-Alcoholic Steatohepatitis Drug Sales Growth Rate by Type (2011-2016)
Table United States Non-Alcoholic Steatohepatitis Drug Sales by Application (2011-2016)
Table United States Non-Alcoholic Steatohepatitis Drug Sales Market Share by Application (2011-2016)
Figure United States Non-Alcoholic Steatohepatitis Drug Sales Market Share by Application in 2015
Table United States Non-Alcoholic Steatohepatitis Drug Sales Growth Rate by Application (2011-2016)
Figure United States Non-Alcoholic Steatohepatitis Drug Sales Growth Rate by Application (2011-2016)
Table Genfit SA Basic Information List
Table Genfit SA Non-Alcoholic Steatohepatitis Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Genfit SA Non-Alcoholic Steatohepatitis Drug Sales Market Share (2011-2016)
Table Intercept Pharmaceuticals, Inc. Basic Information List
Table Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis Drug Sales Market Share (2011-2016)
Table Tobira Therapeutics, Inc. Basic Information List
Table Tobira Therapeutics, Inc. Non-Alcoholic Steatohepatitis Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tobira Therapeutics, Inc. Non-Alcoholic Steatohepatitis Drug Sales Market Share (2011-2016)
Table Galmed Pharmaceuticals Ltd. Basic Information List
Table Galmed Pharmaceuticals Ltd. Non-Alcoholic Steatohepatitis Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galmed Pharmaceuticals Ltd. Non-Alcoholic Steatohepatitis Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-Alcoholic Steatohepatitis Drug
Figure Manufacturing Process Analysis of Non-Alcoholic Steatohepatitis Drug
Figure Non-Alcoholic Steatohepatitis Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-Alcoholic Steatohepatitis Drug Major Manufacturers in 2015
Table Major Buyers of Non-Alcoholic Steatohepatitis Drug
Table Distributors/Traders List
Figure United States Non-Alcoholic Steatohepatitis Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Non-Alcoholic Steatohepatitis Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Non-Alcoholic Steatohepatitis Drug Production Forecast by Type (2016-2021)
Table United States Non-Alcoholic Steatohepatitis Drug Consumption Forecast by Application (2016-2021)